Condition
Node-positive Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Node-positive Breast Cancer clinical trials that are recruiting, at sites in 5 countries (most in United States (3), South Korea (1), Italy (1)). By phase: Phase 2 (3), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 5Countries
Newest Node-positive Breast Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Preoperative chemotherapy with pembrolizumab and a low or high radiation boost for node-positive triple-negative breast cancer | Phase 2 | Chapel Hill, North Carolina | Recruiting | Dec 11, 2025 |
| Targeted sentinel node biopsy for breast cancer patients with limited axillary nodal disease | — | Burnley and 13 other locations | Recruiting | Jul 25, 2025 |
| Screening for metastasis in node-positive breast cancer after treatment | Phase 2 | Tampa, Florida | Recruiting | Feb 18, 2025 |
| Using 68Ga-FAPi-46 PET/CT to study breast cancer | — | Milan, Italy | Recruiting | Jan 24, 2025 |
| Comparing two radiation therapies for node-positive breast cancer | Phase 2 | St Louis, Missouri | Recruiting | Aug 19, 2024 |
| Evaluating targeted axillary dissection in breast cancer with multiple suspicious lymph nodes | — | Essen | Recruiting | Jul 18, 2022 |
| Ovarian function suppression for premenopausal women with low-risk breast cancer | Phase 4 | Seoul, Korea and 1 other locations | Recruiting | Apr 18, 2022 |
All recruiting trials (7)
-
Preoperative chemotherapy with pembrolizumab and a low or high radiation boost for node-positive triple-negative breast cancer
This study tests whether giving a low or high radiation boost together with preoperative chemotherapy and pembrolizumab can better activate the immune system in people with node‑positive triple‑negative breast cancer.
-
Targeted sentinel node biopsy for breast cancer patients with limited axillary nodal disease
This audit will test if removing the marked node along with the sentinel nodes can identify people with only 1–2 positive axillary nodes so some can avoid a full axillary dissection, for adults with cT1-2 breast cancer and biopsy-proven axillary metastases with no more than two abnormal nodes on imaging.
-
Screening for metastasis in node-positive breast cancer after treatment
This study is testing how often breast cancer spreads to other parts of the body in patients who have had chemotherapy and surgery, by using CT scans to check for any signs of metastasis.
-
Using 68Ga-FAPi-46 PET/CT to study breast cancer
This study is testing a new imaging method using a special agent to see if it can help women with node-positive breast cancer get better information about their tumors before starting treatment.
-
Comparing two radiation therapies for node-positive breast cancer
This study is testing if a new type of radiation therapy that gives higher doses in fewer sessions can help people with node-positive breast cancer just as well as the standard treatment, while also making their lives easier.
-
Evaluating targeted axillary dissection in breast cancer with multiple suspicious lymph nodes
This study is testing if a less invasive surgery called targeted axillary dissection can safely help patients with breast cancer who have multiple suspicious lymph nodes after they receive initial treatment.
-
Ovarian function suppression for premenopausal women with low-risk breast cancer
This study is testing if lowering ovarian function with hormone treatments can help premenopausal women with low-risk breast cancer after surgery feel better and avoid chemotherapy.
Related topics
Quick answers
How many Node-positive Breast Cancer clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), South Korea (1 trial), Italy (1 trial), Germany (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.